C1q nephropathy in a patient complicated with nephrotic syndrome and refractory to steroid therapy

J Microbiol Immunol Infect. 2020 Feb;53(1):183-185. doi: 10.1016/j.jmii.2019.06.005. Epub 2019 Jun 28.

¹ Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
² Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Infectious Disease, Department of Internal Medicine, Wan-Fang, Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address: 89425@w.tmu.edu.tw.
³ Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: 94426@w.tmu.edu.tw.

No abstract available

Keywords: C1q nephropathy; Nephrotic syndrome; Rituximab.

Publication types